WELLS FARGO & COMPANY/MN - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$887,152
-35.7%
32,562
-47.5%
0.00%
Q2 2023$1,378,856
+97.1%
61,971
+91.9%
0.00%
Q1 2023$699,509
+139.2%
32,295
+124.3%
0.00%
Q4 2022$292,403
-5.4%
14,397
+19.2%
0.00%
Q3 2022$309,000
+2.3%
12,079
-4.7%
0.00%
Q2 2022$302,000
-87.8%
12,681
-88.5%
0.00%
-100.0%
Q1 2022$2,478,000
-11.4%
110,081
-22.1%
0.00%0.0%
Q4 2021$2,797,000
-19.1%
141,268
-19.6%
0.00%0.0%
Q3 2021$3,459,000
-24.1%
175,758
-15.1%
0.00%0.0%
Q2 2021$4,555,000
-21.3%
206,994
-14.9%
0.00%0.0%
Q1 2021$5,785,000
-7.5%
243,144
+1.7%
0.00%
-50.0%
Q4 2020$6,255,000
+10.8%
239,077
-26.3%
0.00%0.0%
Q3 2020$5,643,000
-17.8%
324,273
-20.6%
0.00%0.0%
Q2 2020$6,868,000
+164.8%
408,320
+87.2%
0.00%
+100.0%
Q1 2020$2,594,000
+1.8%
218,143
+3.5%
0.00%0.0%
Q4 2019$2,549,000
-9.6%
210,665
+5.6%
0.00%0.0%
Q3 2019$2,819,000
-37.2%
199,400
-50.4%
0.00%0.0%
Q2 2019$4,486,000
-8.0%
402,417
-3.1%
0.00%0.0%
Q1 2019$4,874,000
-39.4%
415,200
-31.1%
0.00%
-66.7%
Q4 2018$8,049,000
+47.7%
602,493
+55.0%
0.00%
+50.0%
Q3 2018$5,449,000
-50.3%
388,706
-44.3%
0.00%
-33.3%
Q2 2018$10,971,000
+27.1%
697,851
+32.9%
0.00%0.0%
Q1 2018$8,635,000
-8.2%
524,900
+0.8%
0.00%0.0%
Q4 2017$9,407,000
-31.9%
520,877
-27.2%
0.00%
-25.0%
Q3 2017$13,805,000
+1117.4%
715,261
+644.4%
0.00%
Q2 2017$1,134,000
-54.6%
96,081
-57.9%
0.00%
-100.0%
Q1 2017$2,499,000
+28.8%
228,072
-14.6%
0.00%0.0%
Q4 2016$1,940,000
+254.0%
267,193
+217.0%
0.00%
Q3 2016$548,000
+108.4%
84,296
+74.7%
0.00%
Q2 2016$263,000
-1.9%
48,241
-16.0%
0.00%
Q1 2016$268,000
+3.1%
57,457
+9.9%
0.00%
Q4 2015$260,000
+16.1%
52,303
-12.1%
0.00%
Q3 2015$224,000
-42.3%
59,507
-8.0%
0.00%
Q2 2015$388,000
+1112.5%
64,661
+1036.0%
0.00%
Q1 2015$32,000
+357.1%
5,692
+130.0%
0.00%
Q4 2014$7,0000.0%2,475
+0.9%
0.00%
Q3 2014$7,000
-41.7%
2,454
-41.6%
0.00%
Q2 2014$12,000
-7.7%
4,201
+44.9%
0.00%
Q1 2014$13,0002,9000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders